P. Lefèvre

602 total citations
38 papers, 258 citations indexed

About

P. Lefèvre is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, P. Lefèvre has authored 38 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Genetics and 7 papers in Immunology. Recurrent topics in P. Lefèvre's work include Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Renal Diseases and Glomerulopathies (4 papers). P. Lefèvre is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Renal Diseases and Glomerulopathies (4 papers). P. Lefèvre collaborates with scholars based in France, United States and Austria. P. Lefèvre's co-authors include J Soubeyrand, Pascale Poullin, Gilles Kaplanski, J.-M. Durand, P Hovette, E. Crétel, Étienne Audureau, Michel Dreyfus, Catherine Deneux‐Tharaux and G. Kaplanski and has published in prestigious journals such as British Journal of Haematology, BJOG An International Journal of Obstetrics & Gynaecology and Sleep Medicine.

In The Last Decade

P. Lefèvre

36 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Lefèvre France 10 105 68 55 48 38 38 258
Ali Rıza Odabaş Türkiye 11 24 0.2× 32 0.5× 31 0.6× 88 1.8× 22 0.6× 35 283
Patsy Vegh Canada 9 328 3.1× 33 0.5× 41 0.7× 19 0.4× 22 0.6× 11 434
A. Thomas United States 7 110 1.0× 21 0.3× 27 0.5× 11 0.2× 23 0.6× 12 338
Thierry Schurmans Belgium 11 62 0.6× 62 0.9× 60 1.1× 266 5.5× 38 1.0× 19 479
Anthea Greenway Australia 12 137 1.3× 32 0.5× 18 0.3× 9 0.2× 47 1.2× 22 313
Analía Sánchez‐Luceros Argentina 11 295 2.8× 96 1.4× 22 0.4× 33 0.7× 123 3.2× 34 440
Alison Lap‐tak China 10 38 0.4× 40 0.6× 119 2.2× 220 4.6× 41 1.1× 36 323
A. Icardi Italy 7 103 1.0× 25 0.4× 12 0.2× 102 2.1× 35 0.9× 16 292
Gagnadoux Mf France 13 29 0.3× 40 0.6× 17 0.3× 201 4.2× 25 0.7× 42 480
Paola Mesiano Italy 9 17 0.2× 31 0.5× 59 1.1× 137 2.9× 22 0.6× 12 300

Countries citing papers authored by P. Lefèvre

Since Specialization
Citations

This map shows the geographic impact of P. Lefèvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Lefèvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Lefèvre more than expected).

Fields of papers citing papers by P. Lefèvre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Lefèvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Lefèvre. The network helps show where P. Lefèvre may publish in the future.

Co-authorship network of co-authors of P. Lefèvre

This figure shows the co-authorship network connecting the top 25 collaborators of P. Lefèvre. A scholar is included among the top collaborators of P. Lefèvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Lefèvre. P. Lefèvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halleck, Fabian, Georg A. Böhmig, Lionel Couzi, et al.. (2024). A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody‐Mediated Rejection. Clinical Transplantation. 38(7). e15383–e15383. 9 indexed citations
2.
Poullin, Pascale & P. Lefèvre. (2011). Intérêt des érythraphérèses à la phase initiale du traitement des hémochromatoses génétiques de type 1 : expérience à propos de 30 cas. Transfusion Clinique et Biologique. 18(5-6). 553–558. 6 indexed citations
4.
Audureau, Étienne, et al.. (2009). Practices for prevention, diagnosis and management of postpartum haemorrhage: impact of a regional multifaceted intervention. BJOG An International Journal of Obstetrics & Gynaecology. 116(10). 1325–1333. 30 indexed citations
5.
Lefèvre, P., et al.. (2009). Évaluation de la mise en place d’une prise en charge régionale des hémorragies du postpartum par un audit des cas graves : étude avant-après (2002–2005). Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 38(3). 209–219. 1 indexed citations
6.
Poullin, Pascale & P. Lefèvre. (2007). L’érythraphérèse thérapeutique : technique et applications cliniques. La Revue de Médecine Interne. 29(4). 290–296. 5 indexed citations
7.
Schleinitz, N., Pascale Poullin, Luc Camoin, et al.. (2007). Le purpura thrombotique thrombocytopénique acquis de l’adulte : actualités. La Revue de Médecine Interne. 29(10). 794–800. 5 indexed citations
8.
Poullin, Pascale, et al.. (2006). Purpura thrombotique thrombocytopénique acquis auto-immun chez l'enfant : à propos d'1 cas. Archives de Pédiatrie. 13(12). 1521–1524. 14 indexed citations
9.
Mugnier, Bénédicte, Pascale Poullin, P. Lefèvre, & Jean Roudier. (2003). Clinical improvement in a patient with severe rheumatoid arthritis and chronic hepatitis B after prosorba column immunoadsorption: A one‐year followup. Arthritis Care & Research. 49(5). 722–723. 6 indexed citations
10.
Crétel, E., et al.. (2001). Thymome et lupus érythémateux disséminé.À propos de deux nouvelles observations et revue de la littérature. La Revue de Médecine Interne. 22(5). 475–484. 9 indexed citations
11.
Rétornaz, F., et al.. (2000). Le purpura thrombotique thrombocytopénique idiopathique ou syndrome de Moschowitz : actualités physiopathologiques et perspectives thérapeutiques. La Revue de Médecine Interne. 21(9). 777–784. 3 indexed citations
12.
Poullin, Pascale, et al.. (1998). Thrombopénie induite par l'héparine: régression rapide de la thrombopénie et de la thrombose après échange plasmatique. À propos d'un cas. La Revue de Médecine Interne. 19(11). 819–822. 5 indexed citations
13.
Lefèvre, P., et al.. (1996). Métabolisme de l'albumine. Annales Françaises d Anesthésie et de Réanimation. 15(4). 464–469. 2 indexed citations
15.
Durand, J.-M., P. Lefèvre, Gilles Kaplanski, et al.. (1995). Sjögren's syndrome and hepatitis C virus infection. Clinical Rheumatology. 14(5). 570–571. 5 indexed citations
16.
Durand, J.-M., E. Crétel, Gilles Kaplanski, et al.. (1994). Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection. Clinical Rheumatology. 13(1). 123–125. 10 indexed citations
17.
Durand, J.-M., et al.. (1994). Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature. Clinical Rheumatology. 13(4). 635–640. 2 indexed citations
18.
Lefèvre, P., et al.. (1993). Facteur XIII et infection par le virus de l'hépatite C. 144(1). 1 indexed citations
19.
Durand, J.-M., et al.. (1991). DAPSONE FOR IDIOPATHIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA IN ELDERLY PATIENTS. British Journal of Haematology. 78(3). 459–460. 31 indexed citations
20.
Lefèvre, P., et al.. (1989). Transfusion autologue par recueil peropératoire pendant les transplantations orthotopiques du foie. Annales Françaises d Anesthésie et de Réanimation. 8(4). 326–333. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026